Eating Disorders

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/07153f/anorexia_nervosa_t) has announced the addition of GlobalData's new report "Anorexia Nervosa Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. GlobalData, the industry analysis specialist,...

A Solana Beach company founded by a former venture capitalist who almost died from drugs and alcohol has raised $7 million in funding and landed major managed care clients including Aetna Inc. for...

LONDON -- Lightlake Therapeutics Inc. (OTCBB: LLTP - News) (the "Company" or "Lightlake"), an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today that it...

Date nights, cozy home-cooked dinners in winter, a shared sundae in summer: Food plays an enjoyable role in most couples' lives. Not so enjoyable, though, when half of a couple is trying to...

HEADNOTE Objective Even though overtime work has been suspected to be a risk factor for ill health, little research has been done to determine the underlying immunological mechanisms. This study investigated the association...

Although Revlimid currently is not approved for the treatment of non-deletion MDS it is used in this setting because of limited alternatives. The rationale for the combination of Telintra and Revlimid is based...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/4935f4/eating_disorders_a) has announced the addition of John Wiley and Sons Ltd's new book "Eating Disorders and the Brain" to their offering. Why is the brain important in eating...

With this issue, Today's Woman magazine officially becomes a "woman." She sometimes has searched for her identity through her pubescent years, as do all girls. But the past few years as a teenager...

EDMONDS, Wash. -- In the wake of a federal court ruling this summer that a California woman's insurance company should pay for residential treatment that she received for anorexia nervosa, psychologist Dr. Gregory...

LONDON -- Lightlake Therapeutics Inc. (OTCBB: LLTP) (the "Company" or "Lightlake"), an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today that it has launched...

LOS ANGELES -- The children's charity Let's Erase the Stigma Educational Foundation (LETS) launched its "Let's Run!" fundraiser at the San Francisco Marathon on July 31, 2011, where athletes raised more than $10,000...

DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/bad822/encyclopedia_of_ad) has announced the addition of Elsevier Science and Technology's new book "Encyclopedia of Adolescence, Three-Volume Set" to their offering. The period of adolescence involves growth, adaptation, and dramatic...

ROCHESTER, Minn. -- The majority of Americans embrace the holiday season as a festive time to eat, drink and celebrate with friends, family and co-workers. For those with eating disorders such as binge...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/0d3173/handbook_of_neuroe) has announced the addition of Elsevier Science and Technology's new report "Handbook of Neuroendocrinology" to their offering. Neuroendocrinology, the discipline concerned with how the nervous system controls...

Neurostimulator Uses Innovative Motion Sensor Technology to Provide Patient Comfort and Convenience MINNEAPOLIS -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food & Drug Administration (FDA) approval of its AdaptiveStim[TM] with RestoreSensor[TM]...

CUPERTINO, Calif. -- CRC Health Corporation ("CRC" or the "Company"), a leading provider of substance abuse treatment and adolescent youth services through its wholly owned consolidated subsidiaries, announced its results for the three...

Enzon's LNA oligonucleotides, which reach their mRNA target without a delivery mechanism, unlike most RNA approaches, target difficult-to-drug pathways with well-established links to cancer survival, proliferation and drug resistance. "The current data further...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/b46b95/visual_diagnosis_i) has announced the addition of John Wiley and Sons Ltd's new book "Visual Diagnosis in Emergency and Critical Care Medicine, 2nd Edition" to their offering. Speed and...

- Encouraging signs of activity also observed in NSCLC at 40 mg daily dose - SOUTH SAN FRANCISCO, Calif. -- Exelixis, Inc. (NASDAQ:EXEL) reported data from two ongoing clinical trials exploring lower starting...